Healthcare, Pharma & Life Sciences

Fairfax, Va. – November 02, 2026 -- Nearly 95,000 social media views of Allergy & Asthma Network's Oral Corticosteroids (OCS) Overexposed campaign were recorded, and 62% of them came from four large states, according to research the nonprofit will present at the American Public Health Association (APHA) 2026 Annual Meeting and Expo in San Antonio, Texas.

Selected states with higher asthma burden and greater barriers to healthcare accounted for smaller shares of views. The campaign educates patients about the risks of repeated oral corticosteroid use and encourages informed conversations with healthcare providers.

Bonn – November 02, 2026 -- Deutsche Krebshilfe is funding six research projects with a total of €3.1 million over three years to examine how social inequality shapes cancer care and what financial damage a diagnosis causes. The new priority program, "Krebs und Armut" (Cancer and Poverty), targets a gap the charity describes as insufficiently researched.

Gerd Nettekoven, the charity's executive board member, said a patient's social and financial situation should not determine the quality of care or the chances of living with and after cancer. He said the program is also meant to give evidence for pressing health and social policy makers to close existing deficits.

ABBOTT PARK, Ill. – November 02, 2026 -- Abbott's investigational Amulet 360 left atrial appendage (LAA) occluder achieved complete closure (zero mm leak) in 96.3% of patients assessed by transesophageal echocardiography (TEE) at one year in the VERITAS pivotal study.

Abbott (NYSE: ABT) presented the data in a late-breaking session at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego on Nov. 1, 2026. The results were published simultaneously in JACC: Cardiovascular Interventions. The device targets people with non-valvular atrial fibrillation (AFib) who may need an alternative to long-term blood-thinning medication.

VERITAS one-year data show stroke-free rates above 98%

More than 98% of patients remained free from ischemic stroke or systemic embolism through one year. More than 98% were free from cardiovascular-related mortality.

DELRAY BEACH – November 02, 2026 -- The dental 3D printing market will grow from USD 4.35 billion in 2026 to USD 10.08 billion by 2031, a CAGR of 18.3%, according to MarketsandMarkets.

Materials segment grows fastest at 21.3% CAGR

By product and service, materials are expected to post the highest CAGR in the forecast period, at 21.3%. By technology, VAT photopolymerization held the largest share in 2025 at 61.5%. The category includes stereolithography (SLA) and digital light processing (DLP), which are used for crowns, bridges, surgical guides, occlusal splints and aligners.

Biocompatible resins allow both temporary and permanent restorations. Small clinics and dental support organizations (DSOs) are adopting the technology as new systems become more affordable, compact and user-friendly, according to the report.

JERSEY CITY – November 02, 2026 -- ABVC BioPharma (NASDAQ: ABVC) has closed a private placement of original issue discount senior convertible promissory notes that generated approximately $3.39 million in gross proceeds, before placement agent fees and offering expenses, WallachBeth Capital LLC announced.

Notes carry $4.1 million principal and a June 2027 maturity

The 17.5% OID Notes have an aggregate principal amount of $4,106,060 and mature on June 30, 2027. Investors in the securities purchase agreement are institutional and other accredited investors.

The notes become convertible into ABVC common stock after the eight-month anniversary of issuance. The conversion price is 85% of the average of the three VWAPs for the three trading days immediately before conversion, subject to a floor price and adjustments set out in the notes.

Washington – November 02, 2026 -- URAC and Asembia have launched a strategic partnership that gives eligible members of Asembia's Group Purchasing Organization (GPO) access to URAC accreditation programs, educational resources and support. The companies describe the arrangement as a streamlined path to URAC accreditation for specialty pharmacies.

Asembia GPO members gain a direct route to independent accreditation

URAC is an independent nonprofit health care accreditor. Asembia provides group purchasing, patient support, technology, data and distribution solutions to the specialty pharmaceutical industry. The collaboration links Asembia's connected GPO membership with URAC's accreditation programs. The stated aim is to help participating pharmacies strengthen quality, operational performance and patient care delivery.

San Diego – November 02, 2026 -- Ivy Fertility has launched Sage Reproductive Center, a Midwestern practice of five physicians operating six clinics in St. Louis, Milwaukee and Chicago, lifting the national network to 75 physicians across 18 practices and 35 locations in 12 states.

The launch takes Ivy Fertility into three new Midwestern states. Sage brings together four reproductive endocrinologists and one obstetrician-gynecologist.

Sage covers the full fertility service line across six clinics

The practice offers fertility evaluation and treatment, fertility preservation, IVF, male infertility care, LGBTQIA+ and third-party reproduction, and recurrent pregnancy loss treatment. Its offering includes Ivy's proprietary Gentle IVF, an approach Ivy says reduces the physical and emotional burden of treatment without compromising outcomes.

UNITED STATES – November 02, 2026 -- CEOs of community-based health plans told the ACHP Symposium that regional insurers can use their smaller size to move faster than larger rivals, even as tighter margins, regulatory change and rising costs squeeze the sector.

Medica CEO Lisa Erickson says AI lets regional plans leapfrog larger competitors

Erickson, President and CEO of Medica, described the current environment as "a time of opportunity." She argued that regional plans can leapfrog on AI because they are small and local, provided they stay focused. Larger organizations carry more resources but also more layers of systems, teams and approvals that slow a change of direction.

SPRINGFIELD – November 01, 2026 -- Baystate Health has folded Baystate Mercy Hospital, its joint venture affiliates and 45 Massachusetts medical group entities into one system, and switched the combined organization to a new Oracle Health Electronic Health Record (EHR) on the same day.

Baystate Health ran a seven-month integration program before the single-day cutover

Preparation covered the hospital and its affiliated clinics. It included moving care teams across the system onto one EHR and launching MyBaystate Health, a new patient portal. Baystate says the aim is to make health information available to providers coordinating care. CEO Peter D. Banko said the focus since April had been on Day 1 readiness for staff, patients and supporting systems.

COLOGNE, GERMANY – November 1, 2026 – Informa Connect will host BIO-Europe 2026 in Cologne, Germany, on November 9–11, 2026, convening more than 6,000 senior executives from the global biotech, pharmaceutical, and investment sectors. The 32nd edition of the conference arrives as senior leaders report renewed confidence in biopharma dealmaking, even though financing challenges continue. Programming focuses on how scientific innovation is financed, developed, and brought to patients, alongside structured one-to-one partnering. For company teams, investors, and pharmaceutical partners, the event combines deal-making, strategic debate, and regional ecosystem access in one setting.